Pharmaceuticals

Global Intravenous Immunoglobulin Market 2025–2029: Competitive Insights and Opportunities

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Intravenous Immunoglobulin Industry By The Forecast Year 2029?

The intravenous immunoglobulin market has seen substantial growth in recent years. This market is projected to expand from $14.66 billion in 2024 to $15.57 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.2%. The expansion observed historically is attributable to factors such as the treatment of primary immunodeficiency disorders, the management of neurological disorders, an increasing geriatric population, advancements in plasma fractionation techniques, expanded indications in neurology, the treatment of infectious diseases, and pediatric immunodeficiency treatment.

The intravenous immunoglobulin market is projected to experience significant expansion over the next few years. It is expected to reach $21.53 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.4%. This anticipated growth during the forecast period can be attributed to the rising occurrence of autoimmune disorders, continuous research in immunology, increasing healthcare spending, a surge in cancer incidence, innovations in immunoglobulin products, and personalized medicine approaches. Prominent trends for the forecast period include the treatment of primary immunodeficiency disorders (PIDD), rapid technological advancements, strategic collaborations and partnerships, improvements in manufacturing processes, new applications in neurology, use in hematology, and progress in immunotherapy.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Intravenous Immunoglobulin Industry?

The growth in the geriatric population is anticipated to propel the intravenous immunoglobulin market. The geriatric population refers to individuals above 65 years of age. As people advance in years, their immune system often functions less effectively, leading to a deficiency of antibodies. Therefore, they require immunoglobulins to provide them with the necessary antibodies. This situation boosts the demand for intravenous immunoglobulins, thus advancing the intravenous immunoglobulin market. For instance, in January 2024, the Population Reference Bureau, a Kenya-based Nonprofit organization, reported that the population of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, marking a 47% rise. This age group’s proportion of the total population is also expected to climb from 17% to 23% over the same period. Consequently, the expanding geriatric population will stimulate the expansion of the intravenous immunoglobulin market.

How Is The Intravenous Immunoglobulin Market Segmented?

The intravenous immunoglobulin market covered in this report is segmented –

1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications

4) By End-User: Hospitals, Clinics, Home Care

Subsegments:

1) By Immunoglobulin G (IgG): Normal IgG, Specific IgG

2) By Immunoglobulin M (IgM): Normal IgM, Specific IgM

3) By Immunoglobulin A (IgA): Normal IgA, Specific IgA

4) By Immunoglobulin E (IgE): Normal IgE, Specific IgE

5) By Immunoglobulin D (IgD): Normal IgD, Specific IgD

How Are Trends Influencing The Intravenous Immunoglobulin Market?

Product innovation is a significant trend gaining momentum in the intravenous immunoglobulin market. Major companies are prioritizing the development of new products, such as liquid immune globulin formulations for treating immunodeficiency diseases, to maintain their competitive position. As an illustration, in December 2023, GC Pharma, a pharmaceutical company based in South Korea, launched Alyglo, which received approval from the US Food and Drug Administration (FDA). This product is a sterile, ready-to-use liquid formulation containing 10% immunoglobulin G (IgG), offering 100 mg/mL of protein, with at least 96% being human IgG derived from pooled human plasma. It is specifically prescribed for the treatment of primary humoral immunodeficiency (PI) in adults aged 17 years and older, covering conditions such as congenital agammaglobulinemia, common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID).

Which Key Players Are Driving Competition In The Intravenous Immunoglobulin Market?

Major companies operating in the intravenous immunoglobulin market are Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma, Intas Pharmaceuticals, Octapharma Pharmazeutika Produktionsges.m.b.H., GC Pharma, Grifols Biologicals Inc., Kamada Ltd., LFB USA, Octapharma Plasma Inc., Panacea Biotec Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

Which Geographies Are Emerging As Strong Markets For The Intravenous Immunoglobulin Industry?

North America was the largest region in the intravenous immunoglobulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Intravenous Immunoglobulin Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8538&type=smp

Browse Through More Reports Similar to the Global Intravenous Immunoglobulin Market 2025, By The Business Research Company

Immunoglobulins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Immunosuppressant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report

Immunofluorescence Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795